AJI-9561
AJI-9561 is a benzoxazole derivative produced by Streptomyces sp. AJI-9561 exhibits cytotoxicity and antibacterial activity. AJI-9561 inhibits the proliferation of Jurkat T cells and mouse P388 leukemia cells, with its IC50 being 0.88 and 1.63 μM respectively. AJI-9561 can be used for research on anti-cancer and antibacterial properties[1].
Product Specifications
CAS Number
[339300-34-4]
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Field of Research
Cancer; Infection
Smiles
O=C(O)C1=C2N=C(OC2=CC=C1)C3=C4N=C(OC4=CC=C3)C5=C(C=CC=C5O)C
Molecular Formula
C22H14N2O5
Molecular Weight
386.36
References & Citations
[1]Sato S, et al. AJI9561, a new cytotoxic benzoxazole derivative produced by Streptomyces sp. J Antibiot (Tokyo) . 2001 Jan;54 (1) :102-4.|[2]Cano-Prieto C, et al. Tü 6176: Characterization of the Nataxazole Biosynthesis Pathway. Chembiochem. 2015 Jul 6;16 (10) :1461-73.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
172054-AF-ML550 100 µL
CD45RO (T200, GP180, LCA, Leukocyte Common Antigen, LY5, Receptor-type tyrosine-Protein phosphatase C, T200 GlycoProtein) (BSA & Azide Free) (MaxLight 550)
Ask
View Details 